Nicole R. LeBoeuf, MD, MPH is an oncodermatologist and clinical translational researcher at Brigham and Women’s/Dana-Farber Cancer Center and Associate Professor of Dermatology at Harvard Medical School.  She is a graduate of the University of Massachusetts Medical School, completed her residency in Dermatology at Columbia University and a fellowship in Cutaneous Oncology at Brigham and Women’s/Dana-Farber Cancer Center at Harvard. At Brigham and Women’s, she serves as the Chief of the Division of Oncodermatology and is the Vice Chair of Dermatology at the Dana-Farber Cancer Institute.  She is the founding director of the Program in Skin Toxicities from Anticancer Therapies, Medical Director of the Immunotherapy Toxicities Program and Clinical Director for the Center for Cutaneous Oncology.  In addition to caring for patients with rare and advanced skin cancers and side effects of cancer treatments, she leads clinical trials to treat these malignancies as well as interventional studies for the prevention or management of adverse effects from cancer therapies.   Her clinical and translational research is focused on understanding epidemiologic, genetic and immunologic mechanisms of dermatologic side effects from cancer therapeutics and studying interventions to mitigate them.